Human Atrial Cardiac Microtissues for Chamber-Specific Arrhythmic Risk Assessment
Human Atrial Cardiac Microtissues for Chamber-Specific Arrhythmic Risk Assessment
复制标题
用于心室特异性心律失常风险评估的人心房心脏微组织
DOI:
10.1007/s12195-021-00703-x
复制
发表时间:
2021
影响因子:
2.8
通讯作者:
Coulombe, Kareen L.
中科院分区:
文献类型:
--
作者:
Soepriatna, Arvin H.;Kim, Tae Yun;Daley, Mark C.;Song, Elena;Choi, Bum-Rak;Coulombe, Kareen L.
IntroductionAlthough atrial fibrillation is the most prevalent disorder of electrical conduction, the mechanisms behind atrial arrhythmias remain elusive. To address this challenge, we developed a robustin vitromodel of 3D atrial microtissue from human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes and evaluated chamber-specific chemical responses experimentally and computationally.MethodsWe differentiated atrial and ventricular cardiomyocytes (aCMs/vCMs) from GCaMP6f-expressing hiPSCs and assessed spontaneous AP activity using fluorescence imaging. Self-assembling 3D microtissues were formed with lactate purified CMs and 5% human cardiac fibroblasts and electrically stimulated for one week before high resolution action potential (AP) optical mapping. AP responses to the atrial-specific potassium repolarizing currentIKur-blocker 4-Aminopyridine (4-AP) and funny currentIf-blocker Ivabradine were characterized within their therapeutic window. Finally, we expanded upon a published hiPSC-CM computational model by incorporating the atrial-specificIKurcurrent, modifying ion channel conductances to match the AP waveforms of our microtissues, and employing the updated model to reinforce our experimental findings.ResultsHigh purity CMs (> 75% cTnT+) demonstrated subtype specification by MLC2v expression. Spontaneous beating rates significantly decreased following 3D microtissue formation, with atrial microtissues characterized by their faster spontaneous beating rate, slower AP rise time, and shorter AP duration (APD) compared to ventricular microtissues. We measured atrial-specific responses, including dose-dependent APD prolongation with 4-AP treatment and dose-dependent reduction in spontaneous activity post-Ivabradine treatment.ConclusionThe presentedin vitroplatform for screening atrial-specific responses is both robust and sensitive, with high throughput, enabling studies focused at elucidating the mechanisms underlying atrial arrhythmias.
登录
查看更多内容
影响因子:
5
作者:
Kim, Jong J.;Yang, Lei;Lin, Bo;Zhu, Xiaodong;Sun, Bin;Kaplan, Aaron D.;Bett, Glenna C. L.;Rasmusson, Randall L.;London, Barry;Salama, Guy
通讯作者:
Salama, Guy
影响因子:
5
作者:
Walden, A. P.;Dibb, K. M.;Trafford, A. W.
通讯作者:
Trafford, A. W.
影响因子:
3.4
作者:
Xie, Yuanfang;Sato, Daisuke;Weiss, James N.
通讯作者:
Weiss, James N.
影响因子:
3
作者:
M. Abdelnabi;Ashraf Ahmed;A. Almaghraby;Y. Saleh;H. Badran
通讯作者:
H. Badran
DOI:
--
发表时间:
2018
期刊:
Herzschrittmachertherapie & Elektrophysiologie
影响因子:
--
作者:
A. Klesen;D. Jakob;R. Emig;P. Kohl;U. Ravens;R. Peyronnet
通讯作者:
R. Peyronnet